Folkers K, Porter T H, Bertino J R, Moroson B
Res Commun Chem Pathol Pharmacol. 1978 Mar;19(3):485-90.
5-Chloro-2,3-dimethyoxy-6-octylmercapto-1,4-benzoquinone (NSC 252188) and 2,3-dimethoxy-5-hydroxy-6-phytyl-1,4-benzoquinone (NSC 277818) inhibited the human cell lines 4265 and K 562c, and the experimental animal tumor line W256; they also showed antitumor activity against Walker carcinosarcoma 256 in rats with cures; they also inhibited the mitochondrial coenzyme Q10-enzymes, succinoxidase and NADH-oxidase. 5-Chloro-2,3-dimethoxy-6-n-dodecylmercapto-1,4-benzoquinone (NSC 220334) and 5-chloro-6-omega-cyclohexylhexylmercapto-2,3-dimethoxy-1,4-benzoquinone (NSC 238136) were also active against the K 562c cell line and showed cures against the Walker carcinosarcoma 256 in rats.
5-氯-2,3-二甲氧基-6-辛基巯基-1,4-苯醌(NSC 252188)和2,3-二甲氧基-5-羟基-6-植基-1,4-苯醌(NSC 277818)抑制人细胞系4265和K 562c以及实验动物肿瘤系W256;它们对大鼠的沃克癌肉瘤256也显示出抗肿瘤活性并可治愈;它们还抑制线粒体辅酶Q10-酶、琥珀酸氧化酶和NADH氧化酶。5-氯-2,3-二甲氧基-6-正十二烷基巯基-1,4-苯醌(NSC 220334)和5-氯-6-ω-环己基己基巯基-2,3-二甲氧基-1,4-苯醌(NSC 238136)对K 562c细胞系也有活性,并且对大鼠的沃克癌肉瘤256显示出治愈效果。